Scientists have discovered that transplanted stem cell-derived brain cells may do far more than simply survive after a stroke ...
NKT therapy, agenT-797, delivers context-dependent immune reprogramming showing activation in cancer and anti-inflammatory benefit in ARDS — ...
A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can ...
Anaveon, a late-stage preclinical biotechnology company focused on reprogramming the immune system for the treatment of autoimmune and inflammatory diseases, today announced that new clinical data ...
Breakthrough in resistance: Mount Sinai scientists report a new method to restore immune cell coordination, reversing immunotherapy resistance in colorectal cancer models. How it works: The strategy ...
The global aquaculture industry faces an urgent need to eliminate antibiotic dependency while sustaining productivity against increasingly complex disease ...
Explore the major milestones of induced pluripotent stem cell (iPSC) research, from Shinya Yamanaka’s discovery to current ...
A new mRNA and lipid nanoparticle (mRNA-LNP) platform could selectively reprogram in vivo cytotoxic effector T cells (Teff), ...
Factor advances next-generation allogeneic and in vivo CAR-T cell therapy programs-Presentations will include latest data ...
Head and neck cancers display notable heterogeneity in their immune cell infiltrates, which reflect intricate spatial arrangements and dynamic networks of ...
GC Therapeutics (GCTx), a pioneering biotechnology company advancing the next generation of cell-based medicines through its TFome™ (Transcription-Factor-ome) induced pluripotent stem cell (iPSC) ...
A coalition of anti-abortion legislators is calling for an end to human embryonic stem cell research at the National Institutes of Health, reviving a debate on the ethical use of aborted fetal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results